Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis

Clinical trial NCT02528877 · WITHDRAWN

Trial details

NCT number: NCT02528877
Sponsor: City of Hope Medical Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia in Remission Primary Myelofibrosis Primary Myelofibrosis, Prefibrotic Stage Secondary Acute Myeloid Leukemia Secondary Myelofibrosis

Start date: 2015-11-01
Primary completion: 2016-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.